CCR6 and inflammatory bowel disease: PSC-IBD and UC were both characterised by a significantly higher frequency of colonic mucosal CCR6 + CD161 + Th17 cells compared with HC [18.62% vs 8.41%, p <0.001; and 15.61% vs 8.41%, p = 0.04, respectively].